Arcutis Biotherapeutics Inc (ARQT) support and resistance · rev $196.5M
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
This page maps Arcutis Biotherapeutics Inc (ARQT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
ARQT currently screens at market cap $1.64B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ARQT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ARQT quote page for the session range and the stock page for the full model.
Not investment advice.